OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
Part of paid clinical trials in Eden Prairie, Minnesota.
- Sponsor
- AstraZeneca
- Study ID
- NCT06355934
- Status
- Recruiting
Conditions
- ATTR Amyloidosis
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- no intervention — OTHERnot applicable, this is an observational retrospective data analysis study; no interventions in the study
Study Details
The overall aim of this observational study is to generate real-world evidence on the pre- and post-diagnosis disease journeys, including baseline characteristics, treatment patterns and selected clinical, economic, and humanistic outcomes (for example Health Related Quality of Life (HRQoL), Neuropathy impairment score, activities of daily living (ADL) assessments) in patients with ATTR amyloidosis, and to better understand how the disease is presented.
Key Dates
- Start date
- Aug 21, 2023
- Status verified
- May 2026
- Primary completion
- Sep 30, 2026
- Completion
- Sep 30, 2026
Study Design
- Enrollment
- 52,121 participants (estimated)
Arms
- Arm: ATTR cardiomyopathyPatients with Transthyretin Amyloidosis Cardiomyopathy
- Arm: ATTR polyneuropathyPatients with Transthyretin Amyloidosis Neuropathy
- Arm: ATTR unknownPatients with ATTR unknown genotype
- Arm: ATTR with mixed phenotypePatients with ATTR mixed phenotype
- Arm: ATTR wild typePatients with Transthyretin Amyloidosis wild type
- Arm: ATTR hereditaryPatients with Transthyretin Hereditary
Primary Outcome Measure
Health Care Resource Utilization (HCRU) - Outpatient visits [ Time Frame: From diagnosis of ATTR amyloidosis (index date), assessed throughout the study until end of follow-up, up to a maximum of 12 years ]
Central Contacts
- AstraZeneca Clinical Study Information Center1-877-240-9479
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Research Site | Eden Prairie | Minnesota | 55344 | - |
Find similar trials in Eden Prairie, MN
By research site
Related Studies
- ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)Recruiting · Alnylam Pharmaceuticals · La Jolla, California